Yahoo
NSE - Delayed Quote INR

Morepen Laboratories Limited (MOREPENLAB.NS)

94.43 -2.67 (-2.75%)
At close: 3:30:01 PM GMT+5:30
Chart Range Bar
Loading chart for MOREPENLAB.NS
  • Previous Close 97.10
  • Open 90.69
  • Bid --
  • Ask --
  • Day's Range 88.36 - 95.00
  • 52 Week Range 33.05 - 150.70
  • Volume 3,164,306
  • Avg. Volume 17,439,472
  • Market Cap (intraday) 51.743B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) 27.53
  • EPS (TTM) 3.43
  • Earnings Date --
  • Forward Dividend & Yield 0.20 (0.22%)
  • 1y Target Est --
  • Moby Rating Neutral

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, NASH/ MASH treatment products, CKD treatment, and anti-depressant drugs; and home diagnostic and point-of-care medical devices products, such as blood glucose monitor and test strips, blood pressure monitors, respiratory devices, ortho support, digital thermometers, digital weighing scale, fertility, nebulizers, pulse oximeters, vaporizers, orthopaedic, stethoscope, and miscellaneous products. It also provides OTC healthcare products; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. In addition, the company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

www.morepen.com

1,919

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

MOREPENLAB.NS
130.31%
S&P BSE SENSEX (^BSESN)
4.95%

1-Year Return

MOREPENLAB.NS
101.38%
S&P BSE SENSEX (^BSESN)
2.66%

3-Year Return

MOREPENLAB.NS
163.50%
S&P BSE SENSEX (^BSESN)
24.66%

5-Year Return

MOREPENLAB.NS
86.62%
S&P BSE SENSEX (^BSESN)
33.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY19
Revenue 1.62B
Earnings 72.91M
Profit Margin 4.50%

Q3

FY18

Q4

FY18

Q1

FY19

Q2

FY19

0
500M
1B
2B
0.0%
2.0%
4.0%
6.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.17%

  • Return on Assets (ttm)

    7.48%

  • Return on Equity (ttm)

    14.61%

  • Revenue (ttm)

    22.86B

  • Net Income Avi to Common (ttm)

    1.87B

  • Diluted EPS (ttm)

    3.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.71B

  • Total Debt/Equity (mrq)

    23.37%

  • Levered Free Cash Flow (ttm)

    182.43M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: